The agreement, effective January 1, 2009, has a three-year initial term and includes an option to extend for two additional years.
InnerCool’s RapidBlue System is a thermal regulating system designed to manage and control patient body temperature. RapidBlue provides rapid or gradual temperature control for all patient sizes. Its closed loop catheter-based system modulates whole body temperature, without fluid introduction or exchange, by circulating cool or warm saline within the interior of the catheter.
Christopher Reinhard, chairman and CEO of Cardium Therapeutics and InnerCool Therapies, said: “We are pleased to partner with Novation, the nation’s leading group purchasing organization. The award of this key supplier contract marks another important milestone in the growing market acceptance of our patient temperature modulation solutions.”